Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Parsaclisib hydrochloride | 1995889-48-9 | 99.3% | 469.34 | 100 MG
SDP

Catalog No. 5000345072
Encompass_Preferred

Parsaclisib hydrochloride is a potent, selective, and orally active inhibitor of PI3Kδ, exhibiting an IC50 of 1 nM at 1 mM ATP. It demonstrates approximately 20000-fold selectivity over other PI3K class I isoforms and is used for research into relapsed or refractory B-cell malignancies.

  • Potent and selective PI3Kδ inhibitor.
  • Orally active.
  • High selectivity (approximately 20000-fold) over other PI3K class I isoforms.
  • Useful for research of relapsed or refractory B-cell malignancies.
  • Inhibits proliferation of MCL and DLBCL cell lines.
  • Inhibits anti-IgM-induced pAKT (Ser473) in Ramos Burkitt's lymphoma cell line.
  • Inhibits proliferation of human, dog, rat, and mouse primary B cells after receptor activation.
  • Inhibits tumor growth in BALB/c mice bearing A20 murine lymphoma cells.
  • Slows Pfeiffer xenograft tumor growth in a dose-dependent manner and is well tolerated.

Catalog No. 50-003-45072 Supplier Medchemexpress LLC Supplier No. HY109068A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Parsaclisib hydrochloride is a potent, selective, and orally active inhibitor of PI3Kδ, exhibiting an IC50 of 1 nM at 1 mM ATP. It demonstrates approximately 20000-fold selectivity over other PI3K class I isoforms and is used for research into relapsed or refractory B-cell malignancies.

  • Potent and selective PI3Kδ inhibitor.
  • Orally active.
  • High selectivity (approximately 20000-fold) over other PI3K class I isoforms.
  • Useful for research of relapsed or refractory B-cell malignancies.
  • Inhibits proliferation of MCL and DLBCL cell lines.
  • Inhibits anti-IgM-induced pAKT (Ser473) in Ramos Burkitt's lymphoma cell line.
  • Inhibits proliferation of human, dog, rat, and mouse primary B cells after receptor activation.
  • Inhibits tumor growth in BALB/c mice bearing A20 murine lymphoma cells.
  • Slows Pfeiffer xenograft tumor growth in a dose-dependent manner and is well tolerated.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.